FERMENTALG (ALGAE.PA)
EUR 0.32
(-0.62%)
EUR 0.32
(-0.62%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -14.14 Million EUR | -43.29% |
| 2022 | -9.87 Million EUR | -44.15% |
| 2021 | -6.85 Million EUR | 0.41% |
| 2020 | -6.87 Million EUR | 0.0% |
| 2019 | - EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.83 Million EUR | 0.0% |
| 2024 Q1 | -2.83 Million EUR | 33.19% |
| 2023 Q4 | -4.23 Million EUR | 0.0% |
| 2023 FY | -14.14 Million EUR | -43.29% |
| 2023 Q3 | -4.23 Million EUR | -49.39% |
| 2023 Q2 | -2.83 Million EUR | 0.0% |
| 2023 Q1 | -2.83 Million EUR | -27.91% |
| 2022 FY | -9.87 Million EUR | -44.15% |
| 2022 Q4 | -2.21 Million EUR | 0.0% |
| 2021 FY | -6.85 Million EUR | 0.41% |
| 2020 FY | -6.87 Million EUR | 0.0% |
| 2019 FY | - EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Nicox S.A. | -20.88 Million EUR | 32.245% |
| European Medical Solutions | -709 Thousand EUR | -1895.487% |
| argenx SE | -272.91 Million EUR | 94.816% |
| BioSenic S.A. | -28.77 Million EUR | 50.837% |
| Celyad Oncology SA | -8.44 Million EUR | -67.472% |
| Hyloris Pharmaceuticals SA | -15.38 Million EUR | 8.01% |
| Onward Medical N.V. | -36.18 Million EUR | 60.897% |
| Oxurion NV | -18.96 Million EUR | 25.415% |
| PHAXIAM Therapeutics S.A. | -23.48 Million EUR | 39.765% |
| Financière de Tubize SA | 88.15 Million EUR | 116.05% |
| UCB SA | 343 Million EUR | 104.125% |